These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 22716133)

  • 1. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
    Arnold JC; Boucher AA; Karl T
    Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
    Morgan CJ; Curran HV
    Br J Psychiatry; 2008 Apr; 192(4):306-7. PubMed ID: 18378995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
    Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
    J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
    Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
    Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis.
    Mielnik CA; Li CK; Ramsey AJ; Salahpour A; Burnham WM; Ross RA
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):174-187. PubMed ID: 36251462
    [No Abstract]   [Full Text] [Related]  

  • 13. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
    Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
    Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.
    Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP
    Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the mechanism whereby cannabis use increases risk of psychosis?
    Luzi S; Morrison PD; Powell J; di Forti M; Murray RM
    Neurotox Res; 2008 Oct; 14(2-3):105-12. PubMed ID: 19073418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
    Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV
    Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
    Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
    Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG; Hallak JEC; Crippa JAS
    Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
    Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
    Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.